| 1.87 -0.24 (-11.37%) | 06-04 09:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 2.9 | 1-year : | 4.49 |
| Resists | First : | 2.48 | Second : | 3.84 |
| Pivot price | 1.89  |
|||
| Supports | First : | 0.28 | Second : | 0.23 |
| MAs | MA(5) : | 1.44 |
MA(20) : | 1.51 |
| MA(100) : | 0.75 |
MA(250) : | 0.96 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 30.4 |
D(3) : | 32.8 |
| RSI | RSI(14): 48.5 |
|||
| 52-week | High : | 3.84 | Low : | 0.28 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ IINN ] has closed above bottom band by 27.7%. Bollinger Bands are 327% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 14 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.43 - 1.44 | 1.44 - 1.45 |
| Low: | 1.25 - 1.26 | 1.26 - 1.27 |
| Close: | 1.27 - 1.29 | 1.29 - 1.3 |
Inspira Technologies Oxy B.H.N. Ltd. is a specialized medical device firm focused on developing, producing, and commercializing respiratory support systems. These systems offer a less invasive alternative to mechanical ventilation (MV) for patients suffering from respiratory failure. Its flagship offering is the Augmented Respiration Technology (ART) system, an innovative respiratory assistance device. The ART system employs a portable, minimally invasive dual-lumen cannula, which is strategically placed in the jugular vein to facilitate extracorporeal direct blood oxygenation, thereby effectively boosting and stabilizing critically low oxygen saturation levels. The company operated under the name Insense Medical Ltd. before rebranding as Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Established in 2018, Inspira Technologies maintains its headquarters in Ra'annana, Israel.
Wed, 17 Jun 2026
Inspira Technologies Oxy BHN Ltd (IINN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Wed, 17 Jun 2026
Inspira Technologies Oxy BHN Ltd (IINN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Thu, 04 Jun 2026
Qtrex Quantum (QTEX) registers 6.67M shares for resale by Citadel CEMF - Stock Titan
Mon, 01 Jun 2026
IINN (IINN) director/holder notifies resale of 95,239 shares via Oppenheimer - Stock Titan
Mon, 01 Jun 2026
Director notifies sale of 60,000 IINN shares (IINN) - Stock Titan
Wed, 20 May 2026
Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" - The Quantum Insider
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 44 (M) |
| Held by Insiders | 3.237e+007 (%) |
| Held by Institutions | 10.2 (%) |
| Shares Short | 360 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.347e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -4 % |
| Return on Assets (ttm) | 713.8 % |
| Return on Equity (ttm) | -127 % |
| Qtrly Rev. Growth | 289000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -184.21 |
| EBITDA (p.s.) | 925.92 |
| Qtrly Earnings Growth | -0.5 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 46.26 |
| Dividend | 0 |
| Forward Dividend | 906790 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|